dipyridamole has been researched along with Atrial Septal Defect in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 33-year-old woman with an atrial septal defect associated with severe pulmonary hypertension underwent suture closure of the defect after assessment of operability by lung biopsy." | 1.32 | Successful weaning from inhaled nitric oxide using dipyridamole. ( Nitta, Y; Saiki, Y; Tabayashi, K; Tsuru, Y, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saiki, Y | 1 |
| Nitta, Y | 1 |
| Tsuru, Y | 1 |
| Tabayashi, K | 1 |
| Nuutinen, LS | 1 |
| Pihlajaniemi, R | 1 |
| Saarela, E | 1 |
| Kärkölä, P | 1 |
| Hollmén, A | 1 |
2 other studies available for dipyridamole and Atrial Septal Defect
| Article | Year |
|---|---|
Successful weaning from inhaled nitric oxide using dipyridamole.
Topics: Adult; Dipyridamole; Female; Heart Septal Defects, Atrial; Humans; Hypertension, Pulmonary; Nitric O | 2003 |
The effect of dipyridamole on the thrombocyte count and bleeding tendency in open-heart surgery.
Topics: Adolescent; Adult; Blood Cell Count; Blood Coagulation; Blood Platelets; Cardiopulmonary Bypass; Dip | 1977 |